These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of a vasopressin-1 selective antagonist, OPC-21268, against ethanol-induced damage of the rat gastric wall. Sugimoto I; Narimiya N; Odagiri M; Ohnishi A; Tanaka T Dig Dis Sci; 1999 Mar; 44(3):503-9. PubMed ID: 10080141 [TBL] [Abstract][Full Text] [Related]
34. Effects of nonpeptide V1a and V2 antagonists on blood pressure fast oscillations in conscious rats. Japundzic-Zigon N Clin Exp Hypertens; 2001 May; 23(4):277-92. PubMed ID: 11349820 [TBL] [Abstract][Full Text] [Related]
35. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats. Bemana I; Nagao S Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975 [TBL] [Abstract][Full Text] [Related]
36. Heart rate and blood pressure variabilities in salt-sensitive hypertension. Piccirillo G; Bucca C; Durante M; Santagada E; Munizzi MR; Cacciafesta M; Marigliano V Hypertension; 1996 Dec; 28(6):944-52. PubMed ID: 8952581 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. Li P; Morris M; Ferrario CM; Barrett C; Ganten D; Callahan MF Am J Physiol; 1998 Oct; 275(4):H1130-7. PubMed ID: 9746459 [TBL] [Abstract][Full Text] [Related]
38. A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease. Nakayama M; Yamada K; Nakano H; Miura Y; Suzuki S; Tuchida H; Yoshida S Clin Nephrol; 1993 Jul; 40(1):58-9. PubMed ID: 8395368 [No Abstract] [Full Text] [Related]
39. Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure. Ikeda T; Iwanaga Y; Watanabe H; Morooka H; Akahoshi Y; Fujiki H; Miyazaki S J Cardiovasc Pharmacol; 2015 Nov; 66(5):487-96. PubMed ID: 26248278 [TBL] [Abstract][Full Text] [Related]
40. The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure. Miura Y; Yamada K; Nakayama M; Nakano H; Suzuki S; Tsuchida H; Yoshida S Clin Nephrol; 1993 Jul; 40(1):60-1. PubMed ID: 8395369 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]